Benchmark Reiterates Buy Rating on Abbott Labs (ABT), Following In-Line Q3 Results
Tweet Send to a Friend
Benchmark reiterated a Buy rating and $145.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, "Abbott Labs reported in-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
